Updated Jul 16, 2026
LoPriore Vincent S has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $250K.
Vincent S. Lopriore is a corporate insider associated with Tharimmune, Inc., where he serves as Director and Executive Chairman. He is also a 10% owner of the company, which focuses on developing therapies for rare diseases.
| Role | Executive Chairman, Director, 10% Owner |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-27 | HEPA | Hepion Pharmaceuticals, Inc. | P — Open-market purchase | 1.25M | $0.04 | $50K |
| 2026-04-27 | HEPA | Hepion Pharmaceuticals, Inc. | P — Open-market purchase | 5.00M | $0.04 | $200K |
Vincent S. Lopriore is a corporate insider associated with Tharimmune, Inc., where he serves as Director and Executive Chairman. He is also a 10% owner of the company, which focuses on developing therapies for rare diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($250K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LoPriore Vincent S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.